Sree Rayalaseema Hi-Strength Hypo Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 11:26 pm

Competitors of Sree Rayalaseema Hi-Strength Hypo Ltd

All Competitor Stocks of Sree Rayalaseema Hi-Strength Hypo Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:10 am

Below is a detailed analysis of the quarterly data for Sree Rayalaseema Hi-Strength Hypo Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 180.00 Cr.. The value appears strong and on an upward trend. It has increased from 160.00 Cr. (Mar 2025) to 180.00 Cr., marking an increase of 20.00 Cr..
• For Expenses, as of Jun 2025, the value is 152.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 143.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 9.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 10.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Mar 2025) to 16.00%, marking an increase of 5.00%.
• For Other Income, as of Jun 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 6.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 28.00%, marking an increase of 9.00%.
• For Net Profit, as of Jun 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.64. The value appears strong and on an upward trend. It has increased from 13.23 (Mar 2025) to 13.64, marking an increase of 0.41.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:59 pm

Growth

Last Updated: September 5, 2025, 1:36 pm

Balance Sheet

Last Updated: October 10, 2025, 3:00 pm

Below is a detailed analysis of the balance sheet data for Sree Rayalaseema Hi-Strength Hypo Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
• For Reserves, as of Mar 2025, the value is 905.00 Cr.. The value appears strong and on an upward trend. It has increased from 785.00 Cr. (Mar 2024) to 905.00 Cr., marking an increase of 120.00 Cr..
• For Borrowings, as of Mar 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 10.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 121.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 100.00 Cr. (Mar 2024) to 121.00 Cr., marking an increase of 21.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,059.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 907.00 Cr. (Mar 2024) to 1,059.00 Cr., marking an increase of 152.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Mar 2024) to 112.00 Cr., marking an increase of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 366.00 Cr.. The value appears strong and on an upward trend. It has increased from 253.00 Cr. (Mar 2024) to 366.00 Cr., marking an increase of 113.00 Cr..
• For Other Assets, as of Mar 2025, the value is 580.00 Cr.. The value appears strong and on an upward trend. It has increased from 551.00 Cr. (Mar 2024) to 580.00 Cr., marking an increase of 29.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,059.00 Cr.. The value appears strong and on an upward trend. It has increased from 907.00 Cr. (Mar 2024) to 1,059.00 Cr., marking an increase of 152.00 Cr..

Notably, the Reserves (905.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Sree Rayalaseema Hi-Strength Hypo Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 50.96. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 50.96, marking an increase of 4.95.
• For Diluted EPS (Rs.), as of Mar 25, the value is 50.96. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 50.96, marking an increase of 4.95.
• For Cash EPS (Rs.), as of Mar 25, the value is 55.22. This value is within the healthy range. It has increased from 52.18 (Mar 24) to 55.22, marking an increase of 3.04.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 535.72. It has increased from 466.47 (Mar 24) to 535.72, marking an increase of 69.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 535.72. It has increased from 466.47 (Mar 24) to 535.72, marking an increase of 69.25.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 371.59. It has decreased from 504.53 (Mar 24) to 371.59, marking a decrease of 132.94.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 76.62. This value is within the healthy range. It has decreased from 77.32 (Mar 24) to 76.62, marking a decrease of 0.70.
• For PBIT / Share (Rs.), as of Mar 25, the value is 72.36. This value is within the healthy range. It has increased from 71.14 (Mar 24) to 72.36, marking an increase of 1.22.
• For PBT / Share (Rs.), as of Mar 25, the value is 69.42. This value is within the healthy range. It has increased from 62.50 (Mar 24) to 69.42, marking an increase of 6.92.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 50.96. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 50.96, marking an increase of 4.95.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 50.96. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 50.96, marking an increase of 4.95.
• For PBDIT Margin (%), as of Mar 25, the value is 20.61. This value is within the healthy range. It has increased from 15.32 (Mar 24) to 20.61, marking an increase of 5.29.
• For PBIT Margin (%), as of Mar 25, the value is 19.47. This value is within the healthy range. It has increased from 14.10 (Mar 24) to 19.47, marking an increase of 5.37.
• For PBT Margin (%), as of Mar 25, the value is 18.68. This value is within the healthy range. It has increased from 12.38 (Mar 24) to 18.68, marking an increase of 6.30.
• For Net Profit Margin (%), as of Mar 25, the value is 13.71. This value exceeds the healthy maximum of 10. It has increased from 9.11 (Mar 24) to 13.71, marking an increase of 4.60.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.71. This value is within the healthy range. It has increased from 9.11 (Mar 24) to 13.71, marking an increase of 4.60.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.51. This value is below the healthy minimum of 15. It has decreased from 9.86 (Mar 24) to 9.51, marking a decrease of 0.35.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.34. This value is within the healthy range. It has decreased from 14.20 (Mar 24) to 12.34, marking a decrease of 1.86.
• For Return On Assets (%), as of Mar 25, the value is 8.16. This value is within the healthy range. It has decreased from 8.64 (Mar 24) to 8.16, marking a decrease of 0.48.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.95 (Mar 24) to 0.64, marking a decrease of 0.31.
• For Current Ratio (X), as of Mar 25, the value is 8.99. This value exceeds the healthy maximum of 3. It has decreased from 9.75 (Mar 24) to 8.99, marking a decrease of 0.76.
• For Quick Ratio (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 2. It has decreased from 9.17 (Mar 24) to 8.38, marking a decrease of 0.79.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.69. This value exceeds the healthy maximum of 8. It has increased from 5.03 (Mar 24) to 9.69, marking an increase of 4.66.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 8.69 (Mar 24) to 0.00, marking a decrease of 8.69.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.66 (Mar 24) to 0.00, marking a decrease of 7.66.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 91.31 (Mar 24) to 0.00, marking a decrease of 91.31.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.34 (Mar 24) to 0.00, marking a decrease of 92.34.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 66.42. This value is within the healthy range. It has increased from 33.31 (Mar 24) to 66.42, marking an increase of 33.11.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 46.73. This value is within the healthy range. It has increased from 23.54 (Mar 24) to 46.73, marking an increase of 23.19.
• For Enterprise Value (Cr.), as of Mar 25, the value is 500.40. It has decreased from 518.25 (Mar 24) to 500.40, marking a decrease of 17.85.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.78, marking an increase of 0.19.
• For EV / EBITDA (X), as of Mar 25, the value is 3.80. This value is below the healthy minimum of 5. It has decreased from 3.90 (Mar 24) to 3.80, marking a decrease of 0.10.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.33, marking an increase of 0.36.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 91.30 (Mar 24) to 0.00, marking a decrease of 91.30.
• For Price / BV (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.05 (Mar 24) to 0.91, marking a decrease of 0.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.33, marking an increase of 0.36.
• For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.10, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness